CAREDX, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
CAREDX, INC. (CDNA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.00 per share for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2025-08-06
- CAREDX, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- CAREDX, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $15.50, a 62.39% decline year-over-year.
- CAREDX, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2022-03-31 was $41.21, a 49.16% decline year-over-year.
- CAREDX, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2021-03-31 was $81.06, a 237.75% increase year-over-year.
- CAREDX, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $13.14, a 4.29% increase from fiscal 2023.
- CAREDX, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $12.60, a 55.56% decline from fiscal 2022.
- CAREDX, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $28.35, a 64.27% decline from fiscal 2021.
- CAREDX, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2021 was $79.35, a 172.59% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-06 | |||
| 2024-12-31 | $13.14 10-K · filed 2025-02-28 | |||
| 2024-09-30 | $12.73 10-Q · filed 2024-11-04 | |||
| 2024-06-30 | $9.29 10-Q · filed 2024-07-31 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | $12.60 10-K · filed 2024-02-28 | |||
| 2023-09-30 | $12.60 10-Q · filed 2023-11-08 | |||
| 2023-06-30 | $12.60 10-Q · filed 2023-08-08 | |||
| 2023-03-31 | $15.50 10-Q · filed 2023-05-10 | |||
| 2022-12-31 | $28.35 10-K · filed 2023-02-27 | |||
| 2022-09-30 | $29.05 10-Q · filed 2022-11-03 | |||
| 2022-06-30 | $34.68 10-Q · filed 2022-08-04 | |||
| 2022-03-31 | $41.21 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | $79.35 10-K · filed 2022-02-24 | |||
| 2021-09-30 | $80.40 10-Q · filed 2021-10-28 | |||
| 2021-06-30 | $80.62 10-Q · filed 2021-07-29 | |||
| 2021-03-31 | $81.06 10-Q · filed 2021-05-05 | |||
| 2020-12-31 | $29.11 10-K · filed 2021-02-24 | |||
| 2020-09-30 | $28.30 10-Q · filed 2020-10-29 | |||
| 2020-06-30 | $24.89 10-Q · filed 2020-08-04 | |||
| 2020-03-31 | $24.00 10-Q · filed 2020-04-30 | |||
| 2019-12-31 | $27.88 10-K · filed 2020-02-28 | |||
| 2019-09-30 | $28.14 10-Q · filed 2019-10-31 | |||
| 2019-06-30 | $28.11 10-Q · filed 2019-08-01 | |||
| 2019-03-31 | $27.52 10-Q · filed 2019-05-08 | |||
| 2018-12-31 | $14.78 10-K · filed 2019-03-06 | |||
| 2018-09-30 | $12.06 10-Q · filed 2018-11-08 | |||
| 2018-06-30 | $11.05 10-Q · filed 2018-08-09 | |||
| 2018-03-31 | $3.61 10-Q · filed 2018-05-10 | |||
| 2017-12-31 | $3.39 10-K · filed 2018-03-22 | |||
| 2017-09-30 | $2.05 10-Q · filed 2017-11-09 | |||
| 2017-06-30 | $1.93 10-Q · filed 2017-08-11 | |||
| 2017-03-31 | $2.33 10-Q · filed 2017-06-09 | |||
| 2016-12-31 | $4.91 10-K · filed 2018-03-22 | |||
| 2016-03-31 | $5.14 10-Q · filed 2016-05-16 | |||
| 2015-12-31 | $6.09 10-K · filed 2018-03-22 | |||
| 2015-09-30 | $6.36 10-Q · filed 2015-11-13 | |||
| 2015-06-30 | $7.74 10-Q · filed 2015-08-12 | |||
| 2015-03-31 | $6.58 10-Q · filed 2015-05-14 | |||
| 2014-12-31 | $11.76 10-K · filed 2017-04-21 | |||
| 2014-09-30 | $12.10 10-Q · filed 2014-11-14 | |||
| 2014-06-30 | $12.40 10-Q · filed 2014-08-28 | |||
| 2013-12-31 | $0.48 10-K · filed 2016-03-29 | |||
| 2012-12-31 | $0.55 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |